Platelet Drug Trial in Coronary Disease Progression

Summary

To determine the effectiveness of the platelet inhibitor drugs dipyridamole and aspirin in reducing the angiographic progression of coronary artery disease over a five-year period and to test the predictive value of the platelet survival half-life in identifying patients with more rapid progression of coronary disease and development of its complications.

Timeline

Start

1979-12

Primary completion

—

Completion

1982-12

Drugs

Indications